Solventum Corporation, based in Saint Paul, Minnesota, is a healthcare company with a diverse portfolio targeting critical customer and patient needs. Despite being relatively new in the market, the company's strong foundation in the Medsurg, Dental Solutions, Health Information Systems, and Purification and Filtration segments positions it well for future growth. The current fundamental ratings suggest moderate potential, making it a stock worth monitoring closely.
The fundamental rating of Solventum Corporation indicates a moderate position in the market, with strengths in areas such as discounted cash flow and return on equity.
Category | Score | Visualization |
---|---|---|
Discounted Cash Flow | 5 | |
Return on Equity | 4 | |
Return on Assets | 4 | |
Debt to Equity | 1 | |
Price to Earnings | 1 | |
Price to Book | 2 |
Historical data provides insights into the stability and changes in the scores over time.
Date | Overall | DCF | ROE | ROA | Debt/Eq | P/E | P/B |
---|---|---|---|---|---|---|---|
2025-08-15 | 3 | 5 | 4 | 4 | 1 | 1 | 2 |
N/A | 0 | 5 | 4 | 4 | 1 | 1 | 2 |
Analyst price targets show potential upside, with a consensus leaning towards a 'Buy' rating.
High | Low | Median | Consensus |
---|---|---|---|
103 | 75 | 82 | 86.67 |
The analyst sentiment reflects optimism, with a majority suggesting 'Buy'.
Recommendation | Count | Visualization |
---|---|---|
Strong Buy | 0 | |
Buy | 3 | |
Hold | 3 | |
Sell | 1 | |
Strong Sell | 0 |
Solventum Corporation presents a balanced investment opportunity with potential for growth in the healthcare sector. The company's diverse portfolio and moderate ratings in key financial metrics suggest room for improvement. Analysts' price targets and sentiment lean positive, indicating optimism about future performance. However, investors should remain cautious and monitor potential fluctuations in the market. Overall, Solventum appears to be a promising albeit medium-risk investment.